Low dopamine D5 receptor density in hippocampus in an animal model of attention-deficit/hyperactivity disorder (ADHD)
- PMID:23541742
- DOI: 10.1016/j.neuroscience.2013.03.036
Low dopamine D5 receptor density in hippocampus in an animal model of attention-deficit/hyperactivity disorder (ADHD)
Abstract
A state of low dopaminergic activity has been implicated in attention-deficit/hyperactivity disorder (ADHD). The clinical symptoms of ADHD include inattention, impulsivity and hyperactivity, as well as impaired learning; dopaminergic modulation of the functions in the hippocampus is important to both learning and memory. To determine dopamine receptor (DR) density in a well-established animal model for ADHD, we quantified the dopamine D5 receptors in the hippocampus in the spontaneously hypertensive rat. We used immunofluorescence microscopy and immunogold electron microscopy to quantify the dopamine D5 receptor density on CA1 pyramidal cell somas and dendrites and dendritic spines in the stratum radiatum and stratum oriens. The density of the dopamine D5 receptors was significantly lower in the cytoplasm of pyramidal cell somas in the spontaneously hypertensive rat compared to the control, indicating a reduced reservoir for insertion of receptors into the plasma membrane. DRs are important for long-term potentiation and long-term depression, hence the deficit may contribute to the learning difficulties in individuals with the diagnosis of ADHD.
Copyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.
Similar articles
- Dopamine D5 receptors are localized at asymmetric synapses in the rat hippocampus.Medin T, Owe SG, Rinholm JE, Larsson M, Sagvolden T, Storm-Mathisen J, Bergersen LH.Medin T, et al.Neuroscience. 2011 Sep 29;192:164-71. doi: 10.1016/j.neuroscience.2011.06.056. Epub 2011 Jun 25.Neuroscience. 2011.PMID:21749912
- Altered α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor function and expression in hippocampus in a rat model of attention-deficit/hyperactivity disorder (ADHD).Medin T, Jensen V, Skare Ø, Storm-Mathisen J, Hvalby Ø, Bergersen LH.Medin T, et al.Behav Brain Res. 2019 Mar 15;360:209-215. doi: 10.1016/j.bbr.2018.12.028. Epub 2018 Dec 12.Behav Brain Res. 2019.PMID:30552946
- N-methyl-D-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit/hyperactivity disorder.Jensen V, Rinholm JE, Johansen TJ, Medin T, Storm-Mathisen J, Sagvolden T, Hvalby O, Bergersen LH.Jensen V, et al.Neuroscience. 2009 Jan 12;158(1):353-64. doi: 10.1016/j.neuroscience.2008.05.016. Epub 2008 May 21.Neuroscience. 2009.PMID:18571865
- Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.van der Kooij MA, Glennon JC.van der Kooij MA, et al.Neurosci Biobehav Rev. 2007;31(4):597-618. doi: 10.1016/j.neubiorev.2006.12.002. Epub 2007 Jan 23.Neurosci Biobehav Rev. 2007.PMID:17316796Review.
- [Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder].Ueno K, Togashi H, Yoshioka M.Ueno K, et al.Nihon Shinkei Seishin Yakurigaku Zasshi. 2003 Feb;23(1):47-55.Nihon Shinkei Seishin Yakurigaku Zasshi. 2003.PMID:12690641Review.Japanese.
Cited by
- Imaging functional and structural brain connectomics in attention-deficit/hyperactivity disorder.Cao M, Shu N, Cao Q, Wang Y, He Y.Cao M, et al.Mol Neurobiol. 2014 Dec;50(3):1111-23. doi: 10.1007/s12035-014-8685-x. Epub 2014 Apr 5.Mol Neurobiol. 2014.PMID:24705817Review.
- Daily administration of yokukansan and keishito prevents social isolation-induced behavioral abnormalities and down-regulation of phosphorylation of neuroplasticity-related signaling molecules in mice.Fujiwara H, Han Y, Ebihara K, Awale S, Araki R, Yabe T, Matsumoto K.Fujiwara H, et al.BMC Complement Altern Med. 2017 Apr 4;17(1):195. doi: 10.1186/s12906-017-1710-7.BMC Complement Altern Med. 2017.PMID:28376888Free PMC article.
- Shared and Distinct Topologically Structural Connectivity Patterns in Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.Qian L, Li Y, Wang Y, Wang Y, Cheng X, Li C, Cui X, Jiao G, Ke X.Qian L, et al.Front Neurosci. 2021 Jun 11;15:664363. doi: 10.3389/fnins.2021.664363. eCollection 2021.Front Neurosci. 2021.PMID:34177449Free PMC article.
- Increased Serum Level of CCL5 in Children with Attention‑Deficit/Hyperactivity Disorder: First Results about Serum Chemokines.Özaslan A, Güney E, Gülbahar Ö, Büyüktaskin D, Arslan B.Özaslan A, et al.Clin Psychopharmacol Neurosci. 2022 Feb 28;20(1):109-117. doi: 10.9758/cpn.2022.20.1.109.Clin Psychopharmacol Neurosci. 2022.PMID:35078953Free PMC article.
- Sansoninto, a traditional herbal medicine, ameliorates behavioral abnormalities and down-regulation of early growth response-1 expression in mice exposed to social isolation stress.Fujiwara H, Tsushima R, Okada R, Awale S, Araki R, Yabe T, Matsumoto K.Fujiwara H, et al.J Tradit Complement Med. 2017 Apr 12;8(1):81-88. doi: 10.1016/j.jtcme.2017.03.004. eCollection 2018 Jan.J Tradit Complement Med. 2017.PMID:29321993Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous